Evaluation of Circadian Hormonal Balance: LC-MS/MS Measurement of Salivary and Serum Steroids in Patients With Congenital Adrenal Hyperplasia
Key facts
- Who runs it
- Assistance Publique - Hôpitaux de Paris
- Where
- France1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Not yet recruiting
- People taking part
- 50 people, planned
- Started
- Sept 2026
- Expected to end
- Sept 2028
- Type of study
- Observational
- Record updated
- 21 July 2026
Who can take part
- Age
- 6 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- Patients aged 6 years or older
- Confirmed diagnosis of congenital adrenal hyperplasia treated with glucocorticoids
- Signed informed consent provided by legal guardians
- Affiliation to a national health insurance system
Who cannot take part
- Patients younger than 6 years of age
- Lesions of the oral mucosa that could interfere with saliva sampling
- Inability to provide the patient or legal representatives with appropriate study information (e.g., poor understanding of French)
- Underage parents
- Lack of affiliation with a social security/health insurance system
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
In congenital adrenal hyperplasia (CAH), lifelong hormone replacement therapy is required to treat adrenal insufficiency and to reduce elevated androgen levels. This is essential to ensure "normal" growth and puberty. Replacement therapy includes hydrocortisone and 9α-fludrocortisone acetate (as a mineralocorticoid substitute). Defining appropriate criteria for evaluating therapeutic goals is a key component of patient follow-up.
Read full original descriptionShow less
Currently, monitoring is generally limited to the quantification of serum 17-hydroxyprogesterone (17OHP), testosterone (T) and delta-4 androstenedione (D4), measured in the morning after an overnight fast and before the morning hydrocortisone dose. However, such single-point serum measurements do not take into account the circadian rhythm of these steroids.
The objective of the study is to evaluate correlations between steroid levels (21-deoxycortisol, 17-hydroxyprogesterone, testosterone, delta-4 androstenedione, and cortisol) measured by LC-MS/MS in multiple at-home self-collected saliva samples and those measured in serum during routine monitoring.
The group in the trial
- CAH pediatric cohort treated with glucocorticoids
Children and adolescents with congenital adrenal hyperplasia followed in the participating pediatric endocrinology centers, with 1-2 routine follow-up visits per year, during which paired serum and salivary steroid measurements are obtained.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 21 July 2026